// App-Quantinova.ai

1603 : Prognostic Parameters in Adults with Acute Lymphoblastic Leukemia at Second Complete Response

Researchers

Presenter

  • Caner Saygin

Principal Investigators

  • Nikolaos Papadantonakis

  • Ryan D Cassaday

  • Matt Kalaycio

  • Mikkael A. Sekeres

  • Sudipto Mukherjee

  • Aaron T. Gerds

  • Betty K. Hamilton

  • Hetty E. Carraway

  • Anjali S. Advani

  • Michaela Liedtke

  • Katrina Fischer

  • Tamara J. Dunn

  • Bhumika Patel

  • Sean Hobson

  • Cassie Zimmerman

  • Jaime Lynn Fensterl

  • Ronald M. Sobecks

Medical Centers

  • Hematology & Oncology, Cleveland Clinic, Cleveland, OH

  • Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

  • Leukemia Program, Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH

  • Taussig Cancer Institute / Leukemia Program, Cleveland Clinic, Cleveland, OH

  • Stanford University Cancer Institute, Stanford, CA

  • Taussig Cancer Institute Cleveland Clinic, Cleveland, OH

  • Division of Hematology, University of Washington School of Medicine, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved